Juan Joanna Yu
Endocrinology, Diabetes & Metabolism · Waldorf, MDNPI 1437189974
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,283 and has fallen 77.7% since, to $286 in 2024.
Across 101 payments — averaging $25.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biocryst US Sales Co., LLC$393
- Novo Nordisk$356
- Pharming Healthcare, Inc.$267
- Lilly USA, LLC$251
- Sanofi-aventis U.S. LLC$207
- AstraZeneca$169
- plus $977 from 19 others
What the payments were for
- Food & beverage$2,612100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biocryst US Sales Co., LLC | 3 | $393 |
| Novo Nordisk | 15 | $356 |
| Pharming Healthcare, Inc. | 2 | $267 |
| Lilly USA, LLC | 15 | $251 |
| Sanofi-aventis U.S. LLC | 12 | $207 |
| AstraZeneca | 8 | $169 |
| AbbVie | 8 | $163 |
| Blueprint Medicines Corporation | 1 | $120 |
| Boehringer Ingelheim | 6 | $110 |
| Shire North American Group Inc | 6 | $104 |
| CSL Behring | 1 | $91 |
| Merck | 5 | $64 |
| Lifescan, Inc. | 2 | $44 |
| Corcept Therapeutics | 2 | $42 |
| Johnson & Johnson | 2 | $32 |
| Abbott | 2 | $31 |
| Pfizer | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Mannkind Corporation | 2 | $23 |
| Radius Health, Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Insulet Corporation | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,620 in reported general payments places this provider in the 60th percentile of 235 endocrinology, diabetes & metabolism providers in Maryland.
See all endocrinology, diabetes & metabolism providers in Maryland →
Other endocrinology, diabetes & metabolism in Waldorf
- Daniel GozziSuitland$1.2M
- Martin SarkarFrederick$1.1M
- Nicholas ArgentoLaurel$1.1M
- Romeu AzevedoCamp Springs$987K
- David BrownRockville$497K
- Philip LevinBaltimore$489K
- Helena RodbardRockville$468K
- Roy PhillipsBel Air$208K
- Eyob MakonnenAnnapolis$205K
- Jawaad KhokharGlen Burnie$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.